期刊
MOLECULAR NUTRITION & FOOD RESEARCH
卷 58, 期 2, 页码 248-255出版社
WILEY
DOI: 10.1002/mnfr.201300333
关键词
Flavonoids; Hops; Human metabolism; Pharmacokinetics; Xanthohumol
资金
- NIH [R21AT005294, S10 RR022589, P30 ES000210, UL1TR000128]
- USANA Health Sciences, Salt Lake City, UT
- Hopsteiner, New York
Scope: Xanthohumol (XN) is a bioactive prenylflavonoid from hops. A single-dose pharmacokinetic (PK) study was conducted in men (n = 24) and women (n = 24) to determine dose-concentration relationships. Methods and results: Subjects received a single oral dose of 20, 60, or 180 mg XN. Blood was collected at 0, 0.25, 0.5, 1, 2, 4, 8, 12, 24, 48, 72, 96, and 120 h. Plasma levels of XN and its metabolites, isoxanthohumol (IX), 8-prenylnaringenin (8PN), and 6-prenylnaringenin (6PN) were measured by LC-MS/MS. Xanthohumol (XN) and IX conjugates were dominant circulating flavonoids among all subjects. Levels of 8PN and 6PN were undetectable in most subjects. The XN PK profile showed peak concentrations around 1 h and between 4-5 h after ingestion. The maximum XN concentrations (C-max) were 33 +/- 7 mg/L, 48 +/- 11 mg/L, and 120 +/- 24 mg/L for the 20, 60, and 180 mg dose, respectively. Using noncompartmental modeling, the area under the curves (AUC(0 ->infinity)) for XN were 92 +/- 68 h x mu g/L, 323 +/- 160 h x mu g/L, and 863 +/- 388 h x mu g/L for the 20, 60, and 180 mg dose, respectively. The mean half-life of XN was 20 h for the 60 and 18 h for the 180 mg dose. Conclusion: XN has a distinct biphasic absorption pattern with XN and IX conjugates being the major circulating metabolites.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据